Currently out of the existing stock ratings of Jason Cassorla, 96 are a BUY (86.49%), 15 are a HOLD (13.51%).

Jason Cassorla

Work Performance Price Targets & Ratings Chart

Analyst Jason Cassorla, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 56.86% that have a potential upside of 34.05% achieved within 258 days.

Jason Cassorla’s has documented 213 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ACHC, Acadia Healthcare Company at 20-Jul-2026.

Wall Street Analyst Jason Cassorla

Analyst best performing recommendations are on ACHC (ACADIA HEALTHCARE COMPANY).
The best stock recommendation documented was for ACHC (ACADIA HEALTHCARE COMPANY) at 2/23/2026. The price target of $22 was fulfilled within 3 days with a profit of $4.62 (26.58%) receiving and performance score of 88.61.

Average potential price target upside

of $55.33 (17.13%) on ELV (ELEVANCE HEALTH).
of $49.74 (23.36%) on HUM (HUMANA).
of $48.95 (21.56%) on HCA (HCA HOLDINGS).

AGTI Agiliti BHG Bright Health Group CANO Cano Health CYH Community Health Systems HCA HCA Holdings SGRY Surgery Partners THC Tenet Healthcare CLOV Clover Health Investments Corp UHS Universal Health Services EHAB Enhabit INNV InnovAge Holding Corp PACS PACS Group ACHC Acadia Healthcare Company CI Cigna Corp CNC Centene Corp ELV Elevance Health HUM Humana AG First Majestic Silver Corp ARDT Ardent Health Partners

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

John Ransom (RAYMOND JAMES)